What is the Food and Drug Administration (FDA) announcing today?
The Agency is announcing today: • A national consumer education campaign to help consumers understand how to safely use OTC pain relievers (analgesics) and fever reducers (antipyretics). • The important educational role healthcare professionals can play in educating consumers in the safe use of these products. 2. What prompted this campaign? In September 2002 FDA’s Non-Prescription Advisory Committee (NDAC) held a public meeting to review the safety and labeling of certain OTC drug products such as acetaminophen, aspirin, and nonsteroidal anti-inflammatory drug (NSAIDs). Specifically, the committee reviewed cases of severe liver injury associated with the use of acetaminophen. They also reviewed cases of stomach bleeding and kidney injury related to the use of aspirin and NSAIDs. The committee recommended changes to the labels of these products to better inform consumers about the ingredients in the products and possible serious side effects with improper use. NDAC also recommended tha
